The Mayo Clinic Breast Cancer Book is a trusted resourcedesignedtohelp patientsandtheirfamilies betterunderstandthedisease,makeinformeddecisionsregardingtheircare,andcopewith the emotional and physical effects of diagnosis andtreatment.The book is designed to demystify breast cancer and givepatients step-by-stepguidanceand tools for whattodoiftheyare at risk or have a diagnosis of breast cancer. The book’smedical co-editors are renowned experts Charles L. Loprinzi,M.D., a breast cancer and oncology specialist and Lynn C.Hartmann, M.D., a breast oncologist and researcher—bothfrom the Mayo Clinic Cancer Center.Using helpful graphics to convey cutting-edge medicalinformation, The Mayo Clinic Breast Cancer Book addressesnumerous questions about breast cancer, including:& Understanding your personal and family risk for breastcancer& How to interpret your biopsy report& Understanding treatment options& Updates on the latest research findings& Living with breast cancer and long-term survivorshipWeaving in personal stories from breast cancer patientsand survivors, The Mayo Clinic Breast Cancer Book isorganized into three parts:& Part 1 includes an overview of cancer in general: What itis, how it develops, and how it spreads.& Part 2 looks specifically at breast cancer and provides acomprehensive discussion of the disease, from risk andprevention to the latest technologies in diagnosis andtreatment. Included in this section are decision guides tohelp determine the best treatment option based on indi-vidual circumstances.& Part 3 focuses on strategies for dealing with the emo-tional, social, spiritual, and physical challenges thataccompany cancer treatment and survival.The Mayo Clinic Breast Cancer Book ($22.95/soft cover,432 pages) is currently available wherever books are sold,beginning on October 1, 2012. Mayo Clinic’s proceeds fromthe book will support medical education and research atMayo.Charles L. Loprinzi, M.D., is a medical oncologist andthe Regis Professor in Breast Cancer Research at MayoClinic Cancer Center, Rochester, MN, USA. He is a pastchair of the Division of Medical Oncology at Mayo Clinic.Dr. Loprinzi has authored more than 350 scientific publica-tions. His primary areas of research involve doctor–patientcommunication and the control of cancer-related symptoms.Dr. Loprinzi is also a recipient of two Susan G. KomenFoundation awards: the Brinker International Award andKomen Foundation Professor of Survivorship Award.Lynn C. Hartmann, M.D., is a medical oncologist and theBlanche R. and Richard J. Erlanger Professor of MedicalResearch at Mayo Clinic Cancer Center, Rochester, MN,USA. Dr. Hartmann led the effort to develop a Women’sCancer Program at Mayo Clinic to advance the scientificunderstanding of breast and gynecologic cancers and toeducate professionals, patients, and the public about thesecancers. With funding from the National Cancer Institute,Department of Defense, American Cancer Society, and theSusan G. Komen Foundation, Dr. Hartmann has authoredmore than 200 research articles. Her focus is on the identi-fication and management of women at high risk of breastcancer.